← Leaderboards
Zdenek Hel
University Of Alabama At Birmingham
$11,247,627
Attributed
$12,489,767
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,489,767 · 9
By mechanism
R01$10,882,467 · 5
R21$1,607,300 · 4
Top collaborators
- Janet Patricia Hapgood6 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- G M Anantharamaiah$8,833,772
- Maria B Grant$24,532,308
- C Roger White$4,758,827
- David T Curiel$31,690,411
- Gerald Michael Pohost$6,462,218
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1InfectionPathogenesisChronicMicrobialMucous MembraneInflammationCellsPlayMorbidity - Disease RateProductionResponseImmuneTissuesAcquired Immunodeficiency SyndromeIntestinesNeutrophilNeutrophil ActivationT-LymphocytePublishingReportingPhenotypeExhibitsDisease Progression
Grant awards (31)
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals$734,114
R01 · FY2025 · DK · contact PI
Neutrophil subpopulations and NETosis in HIV-1 pathogenesis$185,625
R21 · FY2025 · AI · contact PI
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals$704,750
R01 · FY2024 · DK · contact PI
Neutrophil subpopulations and NETosis in HIV-1 pathogenesis$222,750
R21 · FY2024 · AI · contact PI
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals$707,087
R01 · FY2023 · DK · contact PI
Neutrophil dysregulation as a driving mechanism of cardiovascular disease in HIV-1-infection$563,326
R01 · FY2019 · HL · contact PI
Combination treatment for protection against HIV1 and pregnancy$536,621
R01 · FY2019 · HD
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals$324,999
R01 · FY2019 · DK · contact PI
Neutrophil dysregulation as a driving mechanism of cardiovascular disease in HIV-1-infection$569,206
R01 · FY2018 · HL · contact PI
Combination treatment for protection against HIV1 and pregnancy$538,831
R01 · FY2018 · HD
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals$324,999
R01 · FY2018 · DK · contact PI
Neutrophil dysregulation as a driving mechanism of cardiovascular disease in HIV-1-infection$573,015
R01 · FY2017 · HL · contact PI
Combination treatment for protection against HIV1 and pregnancy$540,028
R01 · FY2017 · HD
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals$324,999
R01 · FY2017 · DK · contact PI
Neutrophil dysregulation as a driving mechanism of cardiovascular disease in HIV-1-infection$570,075
R01 · FY2016 · HL · contact PI
Combination treatment for protection against HIV1 and pregnancy$325,041
R01 · FY2016 · HD
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals$324,999
R01 · FY2016 · DK · contact PI
Combination treatment for protection against HIV1 and pregnancy$212,152
R01 · FY2016 · HD
Combination treatment for protection against HIV1 and pregnancy$331,607
R01 · FY2015 · HD
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals$324,999
R01 · FY2015 · DK · contact PI
Neutrophil-mediated immune suppression as a mechanism of HIV-1 pathogenesis.$183,750
R21 · FY2014 · AI · contact PI
Neutrophil-mediated immune suppression as a mechanism of HIV-1 pathogenesis.$220,125
R21 · FY2013 · AI · contact PI
Dysregulation of IgA responses in HIV-1-infected individuals$450,938
R01 · FY2011 · AI · contact PI
Depletion of myeloid-derived suppressor cells (MDSCs) in HIV-1-infection$217,553
R21 · FY2011 · AI · contact PI
Dysregulation of IgA responses in HIV-1-infected individuals$470,152
R01 · FY2010 · AI · contact PI
Depletion of myeloid-derived suppressor cells (MDSCs) in HIV-1-infection$183,125
R21 · FY2010 · AI · contact PI
Dysregulation of IgA responses in HIV-1-infected individuals$474,902
R01 · FY2009 · AI · contact PI
Dysregulation of IgA responses in HIV-1-infected individuals$474,902
R01 · FY2008 · AI · contact PI
Dysregulation of IgA responses in HIV-1-infected individuals$480,725
R01 · FY2007 · AI · contact PI
Immunization with Genetically Modified HSCs.$213,121
R21 · FY2006 · AI · contact PI
Immunization with Genetically Modified HSCs.$181,251
R21 · FY2005 · AI